Publications by authors named "Josef Messinger"

Claim this Profile
T
The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) Best Practice Initiative: Hit to Lead.
Jean Quancard, Anders Bach, Chiara Borsari, Russell Craft, Christian Gnamm, Josef Messinger

ChemMedChem· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preparation and preliminary evaluation of a tritium-labeled allosteric P2X4 receptor antagonist.
Jessica Nagel, Olli Törmäkangas, Katja Kuokkanen, Ali El-Tayeb, Josef Messinger

Purinergic Signal· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Preparation and preliminary evaluation of a tritium-labeled allosteric P2X4 receptor antagonist.
Jessica Nagel, Olli Törmäkangas, Katja Kuokkanen, Ali El-Tayeb, Josef Messinger

Purinergic Signal· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) Best Practice Initiative: Hit Generation.
Jean Quancard, Anna Vulpetti, Anders Bach, Brian Cox, Stéphanie M Guéret, Josef Messinger

ChemMedChem· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug screen in iPSC-Neurons identifies nucleoside analogs as inhibitors of (GC) expression in C9orf72 ALS/FTD.
Mareike Czuppa, Ashutosh Dhingra, Qihui Zhou, Carina Schludi, Laura König, Josef Messinger

Cell Rep· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) Best Practice Initiative: Phenotypic Drug Discovery.
Jean Quancard, Anders Bach, Brian Cox, Russell Craft, Dirk Finsinger, Josef Messinger

ChemMedChem· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The European Federation for Medicinal Chemistry (EFMC) Best Practice Initiative: Validating Chemical Probes.
Jean Quancard, Brian Cox, Dirk Finsinger, Stéphanie M Guéret, Ingo V Hartung, Josef Messinger

ChemMedChem· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutations in Arg143 and Lys192 of the Human Mast Cell Chymase Markedly Affect the Activity of Five Potent Human Chymase Inhibitors.
Parvin Ahooghalandari, Nina Hanke, Michael Thorpe, Andreas Witte, Josef Messinger

PLoS One· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
1-Sulfonyl-6-Piperazinyl-7-Azaindoles as potent and pseudo-selective 5-HT6 receptor antagonists.
Charles-Henry Fabritius, Ullamari Pesonen, Josef Messinger, Raymond Horvath, Harri Salo

Bioorg Med Chem Lett· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and investigation of the anticancer effects of estrone-16-oxime ethers in vitro.
Ágnes Berényi, Renáta Minorics, Zoltán Iványi, Imre Ocsovszki, Eszter Ducza, Josef Messinger

Steroids· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biotechnological production of 20-alpha-dihydrodydrogesterone at pilot scale.
Julia Maria Naumann, Andy Zöllner, Călin-Aurel Drăgan, Josef Messinger, Joachim Adam

Appl Biochem Biotechnol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human 20α-hydroxysteroid dehydrogenase (AKR1C1)-dependent biotransformation with recombinant fission yeast Schizosaccharomyces pombe.
Julia Maria Naumann, Josef Messinger, Matthias Bureik

J Biotechnol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Species used for drug testing reveal different inhibition susceptibility for 17beta-hydroxysteroid dehydrogenase type 1.
Gabriele Möller, Bettina Husen, Dorota Kowalik, Leena Hirvelä, Dariusz Plewczynski, Josef Messinger

PLoS One· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Ligand-based NMR spectra demonstrate an additional phytoestrogen binding site for 17beta-hydroxysteroid dehydrogenase type 1.
Paul J A Michiels, Christian Ludwig, Michel Stephan, Christina Fischer, Gabriele Möller, Josef Messinger

J Steroid Biochem Mol Biol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity study in the class of 6-(3'-hydroxyphenyl)naphthalenes leading to an optimization of a pharmacophore model for 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1) inhibitors.
Sandrine Marchais-Oberwinkler, Martin Frotscher, Erika Ziegler, Ruth Werth, Patricia Kruchten, Josef Messinger

Mol Cell Endocrinol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estrone C15 derivatives--a new class of 17beta-hydroxysteroid dehydrogenase type 1 inhibitors.
Josef Messinger, Bettina Husen, Pasi Koskimies, Leena Hirvelä, Lila Kallio

Mol Cell Endocrinol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo mouse model for analysis of hydroxysteroid (17beta) dehydrogenase 1 inhibitors.
Tarja Lamminen, Taija Saloniemi, Kaisa Huhtinen, Pasi Koskimies, Josef Messinger

Mol Cell Endocrinol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Substituted 6-phenyl-2-naphthols. Potent and selective nonsteroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1): design, synthesis, biological evaluation, and pharmacokinetics.
Sandrine Marchais-Oberwinkler, Patricia Kruchten, Martin Frotscher, Erika Ziegler, Alexander Neugebauer, Josef Messinger

J Med Chem· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis, and biological evaluation of (hydroxyphenyl)naphthalene and -quinoline derivatives: potent and selective nonsteroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1) for the treatment of estrogen-dependent diseases.
Martin Frotscher, Erika Ziegler, Sandrine Marchais-Oberwinkler, Patricia Kruchten, Alexander Neugebauer, Josef Messinger

J Med Chem· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human hydroxysteroid (17-beta) dehydrogenase 1 expression enhances estrogen sensitivity of MCF-7 breast cancer cell xenografts.
Bettina Husen, Kaisa Huhtinen, Taija Saloniemi, Josef Messinger, Hubert H Thole

Endocrinology· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unanticipated formation of ortho-sulfone substituted phenols by anionic thia-Fries rearrangement of (aryl triflate)tricarbonylchromium complexes.
Zhirong Zhao, Josef Messinger, Uwe Schön, Rudolf Wartchow, Holger Butenschön

Chem Commun (Camb)· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New inhibitors of 17beta-hydroxysteroid dehydrogenase type 1.
Josef Messinger, Leena Hirvelä, Bettina Husen, Lauri Kangas, Pasi Koskimies

Mol Cell Endocrinol· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis